A Study Evaluating Toripalimab Injection Combined With Standard Chemotherapy as a First-line Treatment for Locally Advanced or Metastatic Urothelial Carcinoma

NCT04568304 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

364

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced or Metastatic Urothelial Carcinoma

Interventions

BIOLOGICAL: Toripalimab Injection
DRUG: Gemcitabine Hydrochloride for Injection
DRUG: Cisplatin for Injection / Carboplatin Injection
DRUG: Placebo

Sponsor

Shanghai Junshi Bioscience Co., Ltd.